The Best of Main Arena

Pulmonary Valve – SOLACI-SOCIME 2022

solaci
solaci
528
0

✔️ Pulmonary Valve – SOLACI-SOCIME 2022

✔️ SOLACI-SOCIME 2022 Scientific Sessions

👨‍🏫 Contents:

00:10 – How to select the type of THV in pulmonary valve – Dr. Juan Pablo Sandoval (MEX).

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022
Next article
Endovascular Treatment of Femoropopliteal Segment – SOLACI-SOCIME 2022
solaci
solaci

More articles by this author

Advances in Structural Intervention – SOLACI-SOCIME 2022

solaci - 0
✔️ Advances in Structural Intervention - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - Palabras de Bienvenida - Dr. Guering Eid-Lidt (MEX)...

Endovascular Treatment of Femoropopliteal Segment – SOLACI-SOCIME 2022

solaci - 0
✔️ Endovascular Treatment of Femoropopliteal Segment - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - How Palabras de bienvenida - Dr. Luis Virgen...

Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022

solaci - 0
✔️ Complex PCI: Distal Left Main Coronary Artery - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session.  👨‍🏫 Contents: 00:13 - Welcoming words - Dr. Álvaro...

CHRONIC TOTAL OCCLUSION – SOLACI-SOCIME 2022

solaci - 0
✔️ Innovation and Advances in Cardiovascular Intervention (Sponsored by MicroPort) - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session. 👨‍🏫 Content: 00:03 - Welcoming words - Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

The Best of Main Arena

Advances in Structural Intervention – SOLACI-SOCIME 2022

✔️ Advances in Structural Intervention - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - Palabras de Bienvenida -...
solaci -
SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Dr. Andrés Rodríguez - 0
Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...